drugset / Trial / NCT05035680
Proof of Concept Trial of Adjuvant Activity of SWE, a Squalene-based -Oil-in-water Emulsion
RandomizedParallel-groupTriple-blindPrevention
Summary
The purpose of the study is to characterize safety and tolerability of the squalene-based adjuvant candidate SWE and its potential to enhance the immune response to seasonal influenza vaccine antigens in healthy older adults.
Timeline
- Start
- 2022-07-14
- Primary completion
- 2023-03-25
- Completion
- 2023-11-25
Outcome
Outcome not reported
Stopped: “Study cancelled”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | MF59 adjuvanted seasonal influenza vaccine | Vaccine | 0.5 ml | Intramuscular |
| Subject | SWE | Other / unclassified | — | Intramuscular |
| Comparator | Unadjuvanted seasonal influenza vaccine | Vaccine | 0.5 ml | Intramuscular |